Evaluation of Renal Injury After RIRS Using Shear-Wave Elastography

May 22, 2026 updated by: Cengiz Canakci, MD

Assessment of Renal Parenchymal Damage Following Retrograde Intrarenal Surgery Using Shear-Wave Elastography

This study aims to evaluate changes in renal parenchyma following retrograde intrarenal surgery (RIRS) using shear-wave elastography. Renal elastography measurements will be performed in patients undergoing RIRS for kidney stones on the preoperative day, on the first postoperative day, and on the seventh postoperative day. Postoperative pain scores, perioperative outcomes, stone-free status and complications will also be assessed.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥18 years
  • Patients undergoing RIRS for renal stones
  • Stone size between < 20 mm
  • Negative urine culture

Exclusion Criteria:

  • Active urinary tract infection
  • Congenital renal anomalies
  • Solitary kidney
  • Chronic kidney disease
  • Previous PCNL or open surgery
  • Ureteral stricture disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aspiration-assisted ureteral access sheath
Patients will undergo retrograde intrarenal surgery using an aspiration-assisted ureteral access sheath.
Patients undergoing retrograde intrarenal surgery using an aspiration-assisted ureteral access sheath
Active Comparator: Standard ureteral access sheath
Patients will undergo retrograde intrarenal surgery using a standard ureteral access sheath.
Standard ureteral access sheath used during retrograde intrarenal surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Renal Cortical Shear-Wave Elastography Values (kPa)
Time Frame: Elastography assessments will be performed preoperatively, on postoperative day 1, and on postoperative day 7 to evaluate perioperative renal parenchymal changes.
Renal cortical stiffness will be quantitatively evaluated using ultrasound-based shear-wave elastography. Measurements will be obtained from multiple regions of the renal cortex, and the mean value of these measurements will be recorded in kilopascals (kPa). All examinations will be performed using the same ultrasound device and standardized protocol by a single experienced radiologist blinded to the study groups.
Elastography assessments will be performed preoperatively, on postoperative day 1, and on postoperative day 7 to evaluate perioperative renal parenchymal changes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Complications
Time Frame: From surgery to postoperative day 30
Perioperative and postoperative complications assessed according to the Clavien-Dindo classification system.
From surgery to postoperative day 30
Serum Creatinine Level
Time Frame: Preoperative baseline, postoperative day 1, and postoperative day 7
Serum creatinine levels measured to evaluate renal function changes following retrograde intrarenal surgery.
Preoperative baseline, postoperative day 1, and postoperative day 7
Postoperative Fever and Sepsis
Time Frame: From surgery to postoperative day 30
Occurrence of postoperative fever (>38°C) and/or sepsis following surgery.
From surgery to postoperative day 30
Stone-Free Rate
Time Frame: Postoperative month 1
Stone-free status assessed by postoperative imaging.
Postoperative month 1
Renal Resistive Index
Time Frame: Preoperative baseline, postoperative day 1 and postoperative day 7
Renal resistive index values measured using Doppler ultrasonography to evaluate renal vascular resistance following retrograde intrarenal surgery.
Preoperative baseline, postoperative day 1 and postoperative day 7
Mayo Adhesive Probability Score
Time Frame: Preoperative period
Mayo Adhesive Probability (MAP) score calculated using preoperative imaging findings to evaluate the degree of adherent perinephric fat.
Preoperative period
Postoperative Pain Scores
Time Frame: preoperative, postoperative 6th hour, and postoperative 24th hour.
Postoperative pain severity assessed using a 10-point visual analog scale (VAS).
preoperative, postoperative 6th hour, and postoperative 24th hour.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

May 18, 2026

First Submitted That Met QC Criteria

May 22, 2026

First Posted (Actual)

May 29, 2026

Study Record Updates

Last Update Posted (Actual)

May 29, 2026

Last Update Submitted That Met QC Criteria

May 22, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kidney Stone

Clinical Trials on Aspiration-assisted ureteral access sheath

Subscribe